More About Me
Administrative TitleLouis W. Sullivan, MD, Professor of Medicine and Assistant Professor, Boston University Chobanian and Avedisian School of Medicine
ResidencyInternal Medicine/Pediatrics, Brown University/Rhode Island Hospital-Lifespan
FellowshipInfectious Disease, Beth Israel Deaconess Medical Center
Board CertificationsInternal Medicine and Infectious Disease, American Board of Internal Medicine
Special InterestsMedical complications of substance abuse, human immunodeficiency virus (HIV), hepatitis C virus (HCV)
Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.
As the principal teaching affiliate of Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center is devoted to training future generations of healthcare professionals. Learn more about Boston University Chobanian & Avedisian School of Medicine.
Featured on HealthCity
Boston Medical Center learned crucial lessons about public health messaging during community conversations about the COVID-19 vaccine and pandemic.
In a hypothetical firm of 10,000 employees, researchers estimated $232,000 of lost wage value annually due to SUD-related absenteeism.
BMC model may serve as a blueprint for other medical centers committed to increasing access to vaccines through community-based interventions.
By hearing stories of people in underserved neighborhoods, researchers hope to understand and help overcome longstanding barriers to healthcare access
About 10-30% of COVID-19 patients feel effects months later. Effectively treating long-term COVID symptoms means reimaging healthcare systems.
In a webinar hosted by the Roxbury Presbyterian Church, epidemiologist Cassandra Pierre, MD, MPH, addressed a common COVID-19 vaccine question.
ID physicians engaged patients with hepatitis C and substance use disorder on how to best integrate comprehensive treatment into their lives.
Transparency and culturally appropriate communication are key to counteracting the hesitancy that could diminish the impact of a COVID-19 vaccine.
Experts raise concerns for post-pandemic repercussions and call for prioritization of the social determinants within medicine.
A new analysis shows that federally qualified health centers, which serve higher rates of people with HCV, largely aren't testing for the virus.
Young people represent an increasing proportion of all HCV cases, but rates of testing and treatment for this group are poor, research finds.